Department of Maternal-Fetal Medicine, Kaiser Permanente West Los Angeles Medical Center, Los Angeles, California.
Southern California Permanente Medical Group, Pasadena, California.
Am J Perinatol. 2020 Sep;37(11):1110-1114. doi: 10.1055/s-0040-1714060. Epub 2020 Jul 3.
The coronavirus disease 2019 (COVID-19) pandemic has created a need for data regarding the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnant women. After implementing universal screening for COVID-19 in women admitted for delivery, we sought to describe the characteristics of COVID-19 in this large cohort of women.
An observational study of women admitted to labor and delivery units in Kaiser Permanente Southern California (KPSC) hospitals between April 6 and May 11, 2020 who were universally offered testing for SARS-CoV-2 infection ( = 3,963). Hospital inpatient and outpatient physician encounter, and laboratory records were used to ascertain universal testing levels, test results, and medical and obstetrical histories. The prevalence of SARS-CoV-2 infection was estimated from the number of women who tested positive during labor per 100 women delivered.
Of women delivered during the study period, 3,923 (99.0%) underwent SARS-CoV-2 testing. A total of 17 (0.43%; 95% confidence interval: 0.23-0.63%) women tested positive, and none of them were symptomatic on admission. There was no difference in terms of characteristics between SARS-CoV-2 positive and negative tested women. One woman developed a headache attributed to COVID-19 3 days postpartum. No neonates had a positive test at 24 hours of life.
The findings suggest that in pregnant women admitted for delivery between April 6 and May 11, 2020 in this large integrated health care system in Southern California, prevalence of SARS-CoV-2 test positive was very low and all patients were asymptomatic on admission.
· The prevalence of SARS-CoV-2 infection in a large diverse cohort of term pregnant women was 0.43%.. · 99% of women accepted SARS-CoV-2 screening on admission to labor and delivery.. · All women with positive test results were asymptomatic at the time of testing..
2019 年冠状病毒病(COVID-19)大流行需要有关孕妇中严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)感染流行率的数据。在对分娩妇女实施 COVID-19 普遍筛查后,我们试图描述这一大批妇女中 COVID-19 的特征。
对 2020 年 4 月 6 日至 5 月 11 日期间在凯撒永久南加州(KPSC)医院分娩和分娩病房住院的妇女进行的观察性研究,对所有妇女提供 SARS-CoV-2 感染检测( = 3963)。使用医院住院和门诊医生就诊和实验室记录来确定普遍检测水平、检测结果以及医疗和产科病史。从分娩期间检测呈阳性的妇女人数中估算 SARS-CoV-2 感染的患病率,每 100 名分娩妇女中检测呈阳性的妇女人数。
在所研究期间分娩的妇女中,有 3923 名(99.0%)接受了 SARS-CoV-2 检测。共有 17 名(0.43%;95%置信区间:0.23-0.63%)妇女检测呈阳性,且她们入院时均无症状。SARS-CoV-2 阳性和阴性检测妇女的特征没有差异。一名妇女在产后 3 天出现归因于 COVID-19 的头痛。没有新生儿在 24 小时生命时检测呈阳性。
研究结果表明,在 2020 年 4 月 6 日至 5 月 11 日期间在南加州这个大型综合医疗保健系统中分娩的孕妇中,SARS-CoV-2 检测阳性的患病率非常低,所有患者入院时均无症状。
·在一个大型多样化的足月孕妇队列中,SARS-CoV-2 感染的患病率为 0.43%。·99%的妇女在分娩和分娩时接受 SARS-CoV-2 筛查。·所有检测结果呈阳性的妇女在检测时均无症状。